Ning Ding
Impact in
Papers in
-
- Lymphoma Diagnosis and Treatment 17
- Genetics 7
- Chronic Lymphocytic Leukemia Research 7
- Co-authors
- Yongchang Sun (1 shared paper)Ying Chen (1 shared paper)Jun Zhu (17 shared papers)Deliang Wen (5 shared papers)Xiangyang Xue (3 shared papers)Teming Zhang (2 shared papers)Honghe Li (4 shared papers)Zhengying Pan (5 shared papers)
- Journals
- Cancer Cell International (4 papers)PLoS ONE (3 papers)Hematological Oncology (3 papers)BMJ Open (3 papers)BMC Cancer (2 papers)
- Partner nations
- ChinaUnited StatesJapan
In The Last Decade
Ning Ding
81 papers receiving 2k citations
Peers
Comparison fields: 5 of 119
- Oncology 569
- Genetics 111
- Immunology 174
- Pathology and Forensic Medicine 149
- Pulmonary and Respiratory Medicine 247
Countries citing papers authored by Ning Ding
This map shows the geographic impact of Ning Ding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ning Ding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ning Ding more than expected).
Fields of papers citing papers by Ning Ding
This network shows the impact of papers produced by Ning Ding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ning Ding. The network helps show where Ning Ding may publish in the future.
Co-authors
The 25 scholars most cited alongside Ning Ding, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 376 | |
| 2 | 2019 | 253 | |
| 3 | 2014 | 146 | |
| 4 | 2017 | 84 | |
| 5 | 2017 | 82 | |
| 6 | 2016 | 70 | |
| 7 | 2014 | 60 | |
| 8 | 2019 | 51 | |
| 9 | 2012 | 46 | |
| 10 | 2013 | 45 | |
| 11 | 2020 | 45 | |
| 12 | 2014 | 44 | |
| 13 | 2021 | 39 | |
| 14 | 2021 | 39 | |
| 15 | 2019 | 31 | |
| 16 | 2019 | 30 | |
| 17 | 2019 | 30 | |
| 18 | 2016 | 29 | |
| 19 | 2014 | 27 | |
| 20 | Life cycle inventory analysis of fossil energy in China. | 2015 | 27 |
About Ning Ding
Ning Ding is a scholar working on Pathology and Forensic Medicine, Genetics, Oncology, Rheumatology and Immunology, having authored 85 papers that have together received 2.1k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (7 papers), Cancer Immunotherapy and Biomarkers (5 papers), Innovations in Medical Education (5 papers), Gastric Cancer Management and Outcomes (5 papers), Acute Myeloid Leukemia Research (4 papers), Immune cells in cancer (4 papers) and Nanoparticle-Based Drug Delivery (3 papers). The work is most often cited by research in Oncology (569 citations), Genetics (111 citations), Immunology (174 citations), Pathology and Forensic Medicine (149 citations) and Pulmonary and Respiratory Medicine (247 citations). Ning Ding has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yongchang Sun, Ying Chen, Jun Zhu, Deliang Wen, Xiangyang Xue, Teming Zhang, Honghe Li, Zhengying Pan, Zhengchun Kang and Gangqiang Guo. Their work appears in journals such as Cancer Cell International, PLoS ONE, Hematological Oncology, BMJ Open and BMC Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.